Annual Revenue
$38.02 M
-$447.40 M-92.17%
31 December 2023
Summary:
AbCellera Biologics annual revenue is currently $38.02 million, with the most recent change of -$447.40 million (-92.17%) on 31 December 2023. During the last 3 years, it has fallen by -$337.18 million (-89.87%). ABCL annual revenue is now -92.17% below its all-time high of $485.42 million, reached on 31 December 2022.ABCL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$6.51 M
-$816.00 K-11.14%
30 September 2024
Summary:
AbCellera Biologics quarterly revenue is currently $6.51 million, with the most recent change of -$816.00 thousand (-11.14%) on 30 September 2024. Over the past year, it has dropped by -$2.67 million (-29.11%). ABCL quarterly revenue is now -97.94% below its all-time high of $316.58 million, reached on 31 March 2022.ABCL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$32.96 M
-$92.00 K-0.28%
30 September 2024
Summary:
AbCellera Biologics TTM revenue is currently $32.96 million, with the most recent change of -$92.00 thousand (-0.28%) on 30 September 2024. Over the past year, it has dropped by -$5.06 million (-13.31%). ABCL TTM revenue is now -94.54% below its all-time high of $603.21 million, reached on 30 September 2022.ABCL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABCL Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -29.1% | -13.3% |
| 3 y3 years | -89.9% | -95.3% | -91.2% |
| 5 y5 years | +227.5% | +103.2% | +929.2% |
ABCL Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -92.2% | at low | -97.9% | at low | -94.5% | at low |
| 5 y | 5 years | -92.2% | +227.5% | -97.9% | +103.2% | -94.5% | +929.2% |
| alltime | all time | -92.2% | +330.6% | -97.9% | +103.2% | -94.5% | +929.2% |
AbCellera Biologics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.51 M(-11.1%) | $32.96 M(-0.3%) |
| June 2024 | - | $7.32 M(-26.4%) | $33.05 M(-7.6%) |
| Mar 2024 | - | $9.95 M(+8.4%) | $35.79 M(-5.9%) |
| Dec 2023 | $38.02 M(-92.2%) | $9.18 M(+39.1%) | $38.03 M(-24.5%) |
| Sept 2023 | - | $6.60 M(-34.4%) | $50.39 M(-65.3%) |
| June 2023 | - | $10.06 M(-17.5%) | $145.18 M(-19.8%) |
| Mar 2023 | - | $12.19 M(-43.4%) | $181.04 M(-62.7%) |
| Dec 2022 | $485.42 M | $21.55 M(-78.7%) | $485.43 M(-19.5%) |
| Sept 2022 | - | $101.38 M(+120.8%) | $603.21 M(+18.9%) |
| June 2022 | - | $45.92 M(-85.5%) | $507.34 M(+3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $316.58 M(+127.2%) | $489.06 M(+30.3%) |
| Dec 2021 | $375.20 M(+60.9%) | $139.33 M(+2429.6%) | $375.22 M(-15.5%) |
| Sept 2021 | - | $5.51 M(-80.1%) | $443.80 M(-0.9%) |
| June 2021 | - | $27.64 M(-86.4%) | $447.65 M(+3.8%) |
| Mar 2021 | - | $202.74 M(-2.5%) | $431.24 M(+85.0%) |
| Dec 2020 | $233.16 M(+1907.9%) | $207.91 M(+2120.8%) | $233.16 M(+719.5%) |
| Sept 2020 | - | $9.36 M(-16.6%) | $28.45 M(+49.0%) |
| June 2020 | - | $11.23 M(+141.1%) | $19.09 M(+142.9%) |
| Mar 2020 | - | $4.66 M(+45.4%) | $7.86 M(+145.4%) |
| Dec 2019 | $11.61 M(+31.5%) | $3.20 M | $3.20 M |
| Dec 2018 | $8.83 M | - | - |
FAQ
- What is AbCellera Biologics annual revenue?
- What is the all time high annual revenue for AbCellera Biologics?
- What is AbCellera Biologics quarterly revenue?
- What is the all time high quarterly revenue for AbCellera Biologics?
- What is AbCellera Biologics quarterly revenue year-on-year change?
- What is AbCellera Biologics TTM revenue?
- What is the all time high TTM revenue for AbCellera Biologics?
- What is AbCellera Biologics TTM revenue year-on-year change?
What is AbCellera Biologics annual revenue?
The current annual revenue of ABCL is $38.02 M
What is the all time high annual revenue for AbCellera Biologics?
AbCellera Biologics all-time high annual revenue is $485.42 M
What is AbCellera Biologics quarterly revenue?
The current quarterly revenue of ABCL is $6.51 M
What is the all time high quarterly revenue for AbCellera Biologics?
AbCellera Biologics all-time high quarterly revenue is $316.58 M
What is AbCellera Biologics quarterly revenue year-on-year change?
Over the past year, ABCL quarterly revenue has changed by -$2.67 M (-29.11%)
What is AbCellera Biologics TTM revenue?
The current TTM revenue of ABCL is $32.96 M
What is the all time high TTM revenue for AbCellera Biologics?
AbCellera Biologics all-time high TTM revenue is $603.21 M
What is AbCellera Biologics TTM revenue year-on-year change?
Over the past year, ABCL TTM revenue has changed by -$5.06 M (-13.31%)